PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia

Published:2020-07-31 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Dong Yuqing,Han Yixiang,Huang Yisha,Jiang Songfu,Huang Ziyang,Chen Rongrong,Yu Zhijie,Yu Kang,Zhang Shenghui

Funder

Zhejiang Provincial Natural Science Foundation of China

National Natural Science Foundation of China

Wenzhou Municipal Science and Technology Bureau

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Molecular therapy for acute myeloid leukaemia;Coombs;Nat Rev Clin Oncol.,2016

2. Update on rational targeted therapy in AML;Shafer;Blood Rev.,2016

3. Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology;Tallman;J Natl Compr Canc Netw.,2019

4. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment;Mussai;Blood.,2013

5. Elevated frequencies of CD4+ CD25+ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia;Shenghui;Int J Cancer.,2011

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of soluble PD-L1 in prostate cancer;Frontiers in Immunology;2024-07-11

2. The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment;Cancer Letters;2024-07

3. Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies;International Journal of Molecular Sciences;2024-06-08

4. Combination therapy with probiotics and anti-PD-L1 antibody synergistically ameliorates sepsis in mouse model;Heliyon;2024-06

5. Stat5b/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes;International Immunopharmacology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3